1. Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials. (28th August 2020) Authors: Kluetz, Paul G; King-Kallimanis, Bellinda L; Suzman, Daniel; Chang, Elaine; Brave, Michael M; Weinstock, Chana; Bhatnagar, Vishal; Beaver, Julia A; Chuk, Meredith K Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 5(2021) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards. Issue 11 (November 2016) Authors: Bottomley, Andrew; Pe, Madeline; Sloan, Jeff; Basch, Ethan; Bonnetain, Franck; Calvert, Melanie; Campbell, Alicyn; Cleeland, Charles; Cocks, Kim; Collette, Laurence; Dueck, Amylou C; Devlin, Nancy; Flechtner, Hans-Henning; Gotay, Carolyn; Greimel, Eva; Griebsch, Ingolf; Groenvold, Mogens; Hamel, ... Journal: Lancet oncology Issue: Volume 17:Issue 11(2016:Nov.) Page Start: e510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Issue 11 (November 2018) Authors: Thanarajasingam, Gita; Minasian, Lori M; Baron, Frederic; Cavalli, Franco; De Claro, R Angelo; Dueck, Amylou C; El-Galaly, Tarec C; Everest, Neil; Geissler, Jan; Gisselbrecht, Christian; Gribben, John; Horowitz, Mary; Ivy, S Percy; Jacobson, Caron A; Keating, Armand; Kluetz, Paul G; Krauss, Aviva... Journal: Lancet Issue: Volume 5:Issue 11(2018) Page Start: e563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blurring the Lines of Design: Prospective Observational Cohorts and Pragmatic Clinical Trials Characterizing Treatment Effects in Routine Cancer Care. (22nd February 2022) Authors: Rivera, Donna R; Larkins, Erin; Kluetz, Paul G Journal: Oncologist Issue: Volume 27:Number 2(2022) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Issue 2 (February 2020) Authors: Gao, Jennifer J; Cheng, Joyce; Bloomquist, Erik; Sanchez, Jacquelyn; Wedam, Suparna B; Singh, Harpreet; Amiri-Kordestani, Laleh; Ibrahim, Amna; Sridhara, Rajeshwari; Goldberg, Kirsten B; Theoret, Marc R; Kluetz, Paul G; Blumenthal, Gideon M; Pazdur, Richard; Beaver, Julia A; Prowell, Tatiana M Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Demystifying the estimand framework: a case study using patient-reported outcomes in oncology. Issue 10 (October 2020) Authors: Fiero, Mallorie H; Pe, Madeline; Weinstock, Chana; King-Kallimanis, Bellinda L; Komo, Scott; Klepin, Heidi D; Gray, Stacy W; Bottomley, Andrew; Kluetz, Paul G; Sridhara, Rajeshwari Journal: Lancet oncology Issue: Volume 21:Issue 10(2020) Page Start: e488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Encouraging Rigorous Patient-Generated Data All Along the Drug Development Continuum. (28th July 2022) Authors: Bhatnagar, Vishal; Kluetz, Paul G Journal: Journal of the National Cancer Institute Issue: Volume 114:Number 10(2022) Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Exploration of baseline patient-reported side effect bother from cancer therapy. (June 2020) Authors: Roydhouse, Jessica K; King-Kallimanis, Bellinda L; Roy, Pourab; Weinstock, Chana; Krol, Danielle; Daniels, Selena R; Suzman, Daniel L; Beaver, Julia A; Kluetz, Paul G Journal: Clinical trials Issue: Volume 17:Number 3(2020) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Incorporating the patient experience into regulatory decision making in the USA, Europe, and Canada. Issue 5 (May 2018) Authors: Kluetz, Paul G; O'Connor, Daniel J; Soltys, Katherine Journal: Lancet oncology Issue: Volume 19:Issue 5(2018) Page Start: e267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. Issue 2 (February 2020) Authors: Coens, Corneel; Pe, Madeline; Dueck, Amylou C; Sloan, Jeff; Basch, Ethan; Calvert, Melanie; Campbell, Alicyn; Cleeland, Charles; Cocks, Kim; Collette, Laurence; Devlin, Nancy; Dorme, Lien; Flechtner, Hans-Henning; Gotay, Carolyn; Griebsch, Ingolf; Groenvold, Mogens; King, Madeleine; Kluetz, Paul ... Journal: Lancet oncology Issue: Volume 21:Issue 2(2020) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗